I think it’s important to present and discuss what different institutions and different conditions are doing across the country, that way we can all kind of come together, provide that unique learning experience from what have you been doing in your clinic, what if you seen directly with patient care, how can we get together and better collate the data, streamline it, and share our experiences, but also using HOPA as a teaching platform for maybe clinicians who are not as apt to looking at next-generation sequencing and molecular profiling, and kind of the oddities of looking at genome reports, and how do you actually implement these into patients at the bedside...
I think it’s important to present and discuss what different institutions and different conditions are doing across the country, that way we can all kind of come together, provide that unique learning experience from what have you been doing in your clinic, what if you seen directly with patient care, how can we get together and better collate the data, streamline it, and share our experiences, but also using HOPA as a teaching platform for maybe clinicians who are not as apt to looking at next-generation sequencing and molecular profiling, and kind of the oddities of looking at genome reports, and how do you actually implement these into patients at the bedside.
For me, I think any oncology pharmacist should be part of HOPA, it’s a great way to network connect stay current on continuing education, as well as really be with the leaders in the field of oncology and pharmacy. It’s a big group that gives a voice to this subspecialty of pharmacists that allow us to be as a HOPA group, a guiding light for practice and what’s new, what’s coming out, what is best practice, and what you need to know to be a better clinician for your patients.
